Low-dose combination therapy with perindopril and indapamide compared with irbesartan

Clinical Drug Investigation

Volumn 22, Issue 8, 2002, Pages 553-560

  Morgan, Trefor ^a,b   Anderson, Adrianne ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Hypertension Clinic   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INDAPAMIDE; IRBESARTAN; PERINDOPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HUMAN; MALE; MUSCLE CRAMP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0036053323     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222080-00008     Document Type: Article

References (17)

1. ACE inhibitors, β blocking drugs, calcium channel blocking drugs and diuretics for the control of elevated systolic blood pressure in the elderly: A double blind crossover study in previously untreated patients
2. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial
3. Management of difficult to control hypertension
4. Sixth report
5. Interaction in hypertensive man between sodium intake, converting enzyme inhibitor (Enalapril), plasma renin and blood pressure control
6. The effect of perindopril on blood pressure in humans on different sodium intakes
7. Irbesartan and low-dose hydrochlorothiazide combination as long-term therapy for mild-to-moderate hypertension
8. Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension
9. Fixed low-dose combination therapy in hypertension: A dose response study of perindopril and indapamide
10. Long-term efficacy of a new fixed very low-dose ACE-inhibitor/diuretic combination as first line therapy in elderly hypertensive patients
11. Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination: A randomised double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension
12. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril
13. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: Efficacy and safety compared with placebo and enalapril
14. Candesartan cilexetil: Safety and tolerability in healthy volunteers and patients with hypertension
15. Antihypertensive efficacy and intolerability of the low-dose perindopril indapamide combination compared with losartan in the treatment of essential hypertension
16. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol
17. Treatment based on a low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive type 2 diabetic patients